mutant isocitrate dehydrogenase inhibitor idh1 r132h

摘要

" mutant ishitrate dehydrogenase inhibitor idh1 r132h " The present invention relates to (2e) -but-2-enedioic acid 3- (2 - {[4- (trifluoromethoxy) phenyl] amino} -1 - [(1r, 5r) -3,3,5-adduct trimethylcyclohexyl] -1h-benzimidazol-5-yl) propanoic acid (1: 4), methods for preparing this adduct, pharmaceutical compositions comprising this adduct and also the use of such adduct for the preparation of a medicament for treating a disease.